How to document pregnancy counseling for a psychotropic

Pregnancy counseling for a psychotropic is a documented shared decision, not a pregnancy-test checkbox. The note should show current reproductive status (or that you asked), which medicine you discussed, what you said about fetal and maternal risk in ordinary language, alternatives including no medication, the patient’s choice, and what you will monitor if pregnancy is possible or confirmed. “Risks and benefits discussed” does not tell covering call what was decided.

This visit may sit inside a complex med-management note. Keep the counseling block findable.

Confirm reproductive status and timing

Ask. Write the answer.

Last menstrual period, contraception, pregnancy test today if indicated, lactation, and whether they are trying to conceive. For patients who can become pregnant and are on valproate, carbamazepine, lithium, or paroxetine, ask this every visit, not just on the annual form.

If they are already pregnant, document gestational age as known, OB contact, and whether they have an OB who will actually co-manage. If they decline a test, write the decline and that you treated the visit as possibly pregnant for counseling purposes.

Do not assume infertility, same-sex partnership, or age over 40 means you can skip the question. One sentence is enough when the answer is “hysterectomy 2019.”

Name the medication and talk in plain language

Drug, dose, and the kind of risk you discussed. Use current labeling and a teratogen resource you actually opened. Do not invent percentages from memory in the chart. If you quoted a number, cite the source you used that day (label, Reprotox, a perinatal psychiatry consult).

Special cases that need explicit sentences:

• Valproate: neural-tube and neurodevelopmental risk; why it is a last-line mood stabilizer if pregnancy is possible.
• Lithium: Ebstein anomaly discussion, plus the maternal renal and delivery-level plan if they continue.
• Paroxetine: cardiac malformation discussion vs other SSRIs.
• Carbamazepine: neural-tube risk and folate.
• Benzodiazepines and hypnotics: neonatal sedation / floppy infant as a third-trimester issue if relevant.
• Clozapine, MAOIs, stimulants: do not hand-wave. If you are not sure, document a perinatal psychiatry referral rather than a confident guess.

Maternal risk of stopping also belongs here: relapse of psychosis, lithium-responsive mania, postpartum suicide risk. A counseling note that only lists fetal harm is incomplete.

Folate when an anticonvulsant is in play. Lactation if they are postpartum or planning to nurse.

Document alternatives and the patient’s choice

Alternatives: switch to a medicine with a better-known pregnancy record, stop with a monitoring plan, delay pregnancy, add psychotherapy, or continue with OB co-management. Include “no change” if that is what they chose.

Quote or closely paraphrase the decision.

Patient trying to conceive in the next 6 months. Discussed continuing lamotrigine 200 mg vs switching off valproate (already off) vs a lithium start. She declines lithium because of monitoring burden. Agrees to stay on lamotrigine, start prenatal vitamin with folic acid today, and call if a period is late. OB referral placed.

If they choose a path you dislike, chart your recommendation, their choice, and the safety net. Do not bury disagreement.

Write the monitoring plan if pregnancy is possible or confirmed

Who orders the pregnancy test and how often. Who to call. What happens to the dose at a positive test (do not wait three weeks for the next med check to “think about it”).

If pregnant and continuing lithium: obstetric collaboration, level monitoring, delivery plan for holding and restarting, neonatal echo if that is your local protocol. If stopping valproate: how fast, what replaces it, seizure or bipolar relapse plan.

Psychotherapy intensification when you thin the meds. See split treatment if a therapist already owns part of the care.

Sample counseling block

Reproductive: LMP 7/28/2026, using copper IUD, not trying to conceive,
open to pregnancy "in a year or two." UPT not indicated today.

Counseling: sertraline 100 mg for MDD. Discussed SSRI use in pregnancy
in general terms per current label, neonatal adaptation, and relapse
risk if stopped abruptly (last relapse 2024 with SI). Alternative:
switch later to a medicine with a longer pregnancy record if they
prefer, or stop only with a written relapse plan. Patient chooses to
continue sertraline and keep IUD. Prenatal vitamin offered, declined
today. Will revisit if IUD comes out or LMP is late. No valproate
on regimen.

Questions people ask

Do I need a signed extra consent? Follow your malpractice carrier and health system. The progress-note block is the minimum. A scanned handout helps only if you record that they received it.

What if the partner wants to decide? You counsel the patient. You may include the partner with permission. The choice in the chart is the patient’s, unless a guardian is the legal decision-maker.